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addicts emerging not from the traditional milieu changes. As pharmaceutical companies gained
of the urban underclass but from the white control over research and the subsequent
suburban middle-classes, and from the 1980s marketing ofdrug therapies, the faith in science
with the disastrous spread of HIV/AIDS, gave increasingly meant a faith in pharmaceutical
impetus to new non-medical movements like companies. Healy contends that the resulting
Narcotics Anonymous and began to refocus corporatecontrol produces aculture that wasand
medical resources away from the attempt to is dominated by the dictates of apharmaceutical
eliminate drug use towards public health market rather than the needs ofpublic health.
initiatives like methadone and needle exchange. Healy combines an impressive collection of
This recent-and still only partial-shift of contemporary medical publications from the
emphasis makes Acker's book especially timely, nineteenth and twentieth centuries with avariety
revealing the pathological paradigm ofthe early ofsecondary workstoconstructacomprehensive
twentieth century to have been not so much history ofpsychopharmacology. His book
the application ofmodern science that it claimed offers a number of colourful anecdotes that
to be, as a vestigial, though powerful and breathe life into a chronologically-organized
massively-funded, extension of the generation chain of discoveries and developments.
of Victorian "moral management" which In the first halfofthebook, Healy provides an
preceded it. historical analysis of developments before the
Second World War, concentrating on
Mike Jay, professional accomplishments, controversies,
London and individual researchers that contributed to
the proliferation of psychopharmacological
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psychopharmacology, Cambridge, MA, and latter half ofthe book, he identifies the growing
London, Harvard University Press, 2002, influence of pharmaceutical companies in
pp. 469, £27.50 (hardback 0-674-00619-4). medical research and offers a more explicit
political critique of the corporate agenda.
Does marketing determine culture? And, what Intermittently, Healy uses comparisons with
influence does culture have on modern western Japanese case studies, as a non-western example
medicine? These questions are central to David of responses to modern psychopharmacology,
Healy's latest contribution to the history of to reinforce the substantial differences incultural
medicine in his provocative study of the rise of attitudes towards mental illness. By the book's
psychopharmacology. This book examines the conclusion, readers are left with a bleak
intersection of commercial and scientific prognosis for the disentanglement of corporate
interests in an historical investigation of interests from western medicine and, moreover,
the growing influence of pharmaceutical western culture.
companies in modern medicine, particularly in While Healy presents a compelling argument
mental health services. In this study, the history for recognizing the dangerous liaisons between
ofpsychopharmacology illuminates shifts in the corporate and public health interests, several
faith in science in nineteenth- and twentieth- other areas in his book leave the reader wanting.
century western culture. By tracing The author considers only briefly the place
psychopharmacological developments from the ofethics ineither acorporate oramedical setting,
early nineteenth century, Healy illustrates how an intriguing omission considering the subject
western societies increasingly have come to rely matter. Although Healy makes a strong argument
on modern biological medicine for revealing for the connection between corporate
the blueprints for human life, culminating in the advertising and western societies' attitudes to the
completion of the Human Genome Project. appropriate treatment of mental illness, his
Westerners became conditioned to believe in the comparison with Japan raises questions of
superiority of drug treatments over lifestyle whether the observed differences in
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pharmaceutical use are due to the relative power
of the multinationals or to more fundamental
"cultural differences" in attitudes to health
and healing. Readers are led to believe that
western society isdestined foradismal future of
market-dominated culture. Healy offers no
alternatives for charting a better course:
his suggestions for reform would be welcome.
The creation ofpsychopharmacology makes
a substantial contribution to the history of
medicine with its rich history of
psychopharmacological developments and an
intriguing analysis ofthe relationship between
culture and medicine overthe last twocenturies.
It is refreshing in its provocative analysis of a
western culture that faithfully consumes
psychopharmacological treatments as directed
by the corporate media. While this book often
presents advanced technical and scientific
detail-which this reviewer cannot fully
evaluate-Healy admirably merges
biochemistry and political critiques
in an accessible manner. As a trained clinical
psychopharmacologist, Healy gives us a rare
insider's view of the tangled web ofcorporate
imperatives and public interests that come into
play in the world of modern medicine.
Erika Dyck,
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Interest in innovations in health and medicine
has been growing in recent years amongst
sociologists, economists and a politically
interested general public, confronted with high
tech medicine and soaring health care costs.
This volume offers a welcome historical
perspective to these debates and is a useful
addition to the two essay collections on the
subject published in the early 1990s by John
Pickstone (Medical innovations in historical
perspective, Basingstoke, 1992) and Ilana Lowy
(Medicine and change: historical and
sociological studies ofmedical innovation,
Paris, 1993). Like these earlier volumes, the
papers in Jennifer Stanton's collection argue
against the assumption that innovation takes
place because the new is always better than the
old. Rather, asStanton andherco-authors seekto
persuade us, changes in medical practices are
products oftheir social, political and economic
contexts. Practices are what most papers in the
volume are focusing on, rather than devices
and machines. With many of the authors
influenced by the Sociology of Scientific
Knowledge(SSK)andtheSocialConstruction of
Technology (SCOT), the spotlight is on the
diffusion, the uses of and resistance to, new
techniques, technologies and organizational
innovations, rather than on acts of invention.
Comparisonbetween differentcontexts, local,
regional, national orhistorical, is acentral theme
of the book, and most papers deal with recent
developments. The focus of papers by Debbie
Nicholson, HelenValierandRobertaBivins,and
Jennifer Stanton ispredominantly local, regional
and British. Nicholson compares the uptake of
obstetrical ultrasound and its adaptation in the
1970s and 1980s in two different hospitals in
Scotland, an average size maternity hospital
andasmall, remoteislandhospital. Shefindsthat
not only the ultrasound machines were
reconfigured to match particular demands-
portability was a central concern-but also
medical hierarchies andthe interactions between
local actors. Valier and Bivins compare local
servicesestablishedinManchesterforthecareof
sufferers from three different chronic diseases,
diabetes mellitus, sickle cell anaemia and
thalassaemia, analysing how the different
professional and ethnic identities of promoters,
practitioners and patients shaped these services.
Stanton studies the diffusion ofand resistance to
two different dialysis techniques for the
treatment of chronic kidney failure in the UK
since the 1960s, high tech haemodialysis, and
rather low-tech continuous ambulatorial
peritoneal dialysis (CAPD). She analyses how
both techniques configured their users, i.e.
practitionersandpatients(theconfigureduserisa
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